Estudio comparativo entre la utilización de TSH recombinante y la estimulación endógena con TSH. Valoración en el seguimiento de los pacientes con carcinoma diferenciado de tiroides
Authors:
- J. Castell ConesaJCJ. Castell Conesa
- G. Obiols AlfonsoGAG. Obiols Alfonso
- P. Pifarré MontanerPMP. Pifarré Montaner
- M. Negre BusóMBM. Negre Busó
- C. García AlonsoCAC. García Alonso
- P. Galofré MoraPMP. Galofré Mora
- J. Mesa MantecaJMJ. Mesa Manteca
- 31 August 2006
- journal article
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 25 (4) , 236-241
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Changing Concepts in the Management of Differentiated Thyroid CancerSeminars in Nuclear Medicine, 2005
- Aplicación de la TSH humana recombinante en el protocolo diagnóstico del cáncer diferenciado de tiroidesRevista Española de Medicina Nuclear, 2005
- Recombinant Human Thyrotropin is Helpful in the Follow-Up and 131 I Therapy of Patients with Thyroid Cancer: A Report of the Results and Benefits Using Recombinant Human Thyrotropin in Clinical RoutineThyroid®, 2005
- Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid CarcinomaThyroid®, 2005
- La TSH humana recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroidesRevista Española de Medicina Nuclear, 2003
- A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- EANM Procedure Guideline for Therapy with iodine-131European Journal of Nuclear Medicine and Molecular Imaging, 2003
- Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancerEuropean Journal of Endocrinology, 2003
- Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.Endocrine-Related Cancer, 2002
- Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2001